Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 5/20 | 1.00 |
| ▸ | LTA4H | P09960 | 5/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.98 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.98 |
| ▸ | CYP2C8 | P10632 | 4/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.98 |
| ▸ | CYP2B6 | P20813 | 4/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.98 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.98 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.98 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.98 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | MTOR | P42345 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4886648 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL29564343 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL4885163 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL29929375 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL4885150 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL30335074 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| SCHEMBL4886657 | 1.00 | HTR1A (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| Shogaol SCHEMBL971812 | 0.99 | LTA4H (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| Shogaol SCHEMBL49054 | 0.99 | LTA4H (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 | |
| Shogaol SCHEMBL10523393 | 0.99 | LTA4H (1.00) | HTR1ALTA4HCYP3A4CYP1A2TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3463588-B1 | USE OF GINGER ROOT CO2 EXTRACT | SYMRISE AG (DE) | 2025-09-17 | — | — | EP | claimed |
| EP-4580612-A1 | USE OF NRF2 ACTIVATORS FOR THE TREATMENT OF CEREBRAL SMALL VESSEL DISEASE | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-07-09 | — | — | EP | claimed |
| US-12342845-B2 | Aerosol-generating substrate comprising Zingiber species | PHILIP MORRIS PRODUCTS S.A. (CH) | 2025-07-01 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| EP-4405045-A1 | COSMETIC COMPOSITIONS CONTAINING CANNABIDIOL AND ZINGIBER EXTRACT | Bionorica SE (DE) | 2024-07-31 | — | — | EP | claimed |
| WO-2024047248-A1 | USE OF NRF2 ACTIVATORS FOR THE TREATMENT OF CEREBRAL SMALL VESSEL DISEASE | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-03-07 | — | — | WO | claimed |
| EP-4048095-B1 | NOVEL AEROSOL-GENERATING SUBSTRATE COMPRISING ZINGIBER SPECIES | PHILIP MORRIS PRODUCTS SA (CH) | 2023-11-29 | — | — | EP | claimed |
| WO-2023046730-A1 | COSMETIC COMPOSITIONS CONTAINING CANNABIDIOL AND ZINGIBER EXTRACT | BIONORICA SE (DE) | 2023-03-30 | — | — | WO | claimed |
| US-11559557-B2 | Medicament comprising ginger root CO2 extract | SYMRISE AG (DE) | 2023-01-24 | — | — | US | claimed |
| US-20220369690-A1 | NOVEL AEROSOL-GENERATING SUBSTRATE COMPRISING ZINGIBER SPECIES | PHILIP MORRIS PRODUCTS S.A. (CH) | 2022-11-24 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| EP-4048095-A1 | NOVEL AEROSOL-GENERATING SUBSTRATE COMPRISING ZINGIBER SPECIES | Philip Morris Products, S.A. (CH) | 2022-08-31 | — | — | EP | claimed |
| CN-114727646-A | Novel aerosol-generating substrate comprising ginger species | 菲利普莫里斯生产公司 | 2022-07-08 | — | — | CN | claimed |
| US-20220133835-A1 | ANTIDIABETIC COMPOSITION COMPRISING GINGER EXTRACT OBTAINED FROM MICROWAVE-PROCESSED GINGER AND METHOD OF PREVENTING OR TREATING DIABETIS MELLITUS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-05-05 | — | — | US | claimed |
| EP-4746880-A2 | METHODS OF TREATING DILATED CARDIOMYOPATHY | Regencor, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12588699-B2 | Aerosol-generating substrate | PHILIP MORRIS PRODUCTS S.A. (CH) | 2026-03-31 | — | — | US | disclosed |
| US-20260034107-A1 | SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING SICKLE CELL DISEASE AND RELATED COMPLICATIONS | VTV THERAPEUTICS LLC (US) | 2026-02-05 | — | — | US | disclosed |
| CN-114727646-A | Novel aerosol-generating substrate comprising ginger species | 菲利普莫里斯生产公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-114727646-A | Novel aerosol-generating substrate comprising ginger species | 菲利普莫里斯生产公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20220133835-A1 | ANTIDIABETIC COMPOSITION COMPRISING GINGER EXTRACT OBTAINED FROM MICROWAVE-PROCESSED GINGER AND METHOD OF PREVENTING OR TREATING DIABETIS MELLITUS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11559557-B2 | Medicament comprising ginger root CO2 extract | CRY1, GRK1, GPER1 | HTR1A 514/4885LTA4H 683/4885CYP3A4 186/4885 |
| US-20220133835-A1 | ANTIDIABETIC COMPOSITION COMPRISING GINGER EXTRACT OBTAINED FROM MICROWAVE-PROCESSED GINGER AND METHOD OF PREVENTING OR TREATING DIABETIS MELLITUS | IAPP, DPP4, DPP8 | HTR1A 3928/4885LTA4H 3223/4885CYP3A4 486/4885 |
| US-20260034107-A1 | SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING SICKLE CELL DISEASE AND RELATED COMPLICATIONS | HBB, HBZ, HBG1 | HTR1A 2586/4885LTA4H 2663/4885CYP3A4 1537/4885 |
| US-12588699-B2 | Aerosol-generating substrate | CCT5, PRUNE1, DSTN | HTR1A 2279/4885LTA4H 3290/4885CYP3A4 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.